Inhibitors of hepatitis C virus NS3•4A protease.: Part 3:: P2 proline variants

被引：49

作者：

Perni, RB ^{[1
]}

Farmer, LJ ^{[1
]}

Cottrell, KM ^{[1
]}

Court, JJ ^{[1
]}

Courtney, LF ^{[1
]}

Deininger, DD ^{[1
]}

Gates, CA ^{[1
]}

Harbeson, SL ^{[1
]}

Kim, JL ^{[1
]}

Lin, C ^{[1
]}

Lin, K ^{[1
]}

Luong, YP ^{[1
]}

Maxwell, JP ^{[1
]}

Murcko, MA ^{[1
]}

Pitlik, J ^{[1
]}

Rao, BG ^{[1
]}

Schairer, WC ^{[1
]}

Tung, RD ^{[1
]}

Van Drie, JH ^{[1
]}

Wilson, K ^{[1
]}

Thomson, JA ^{[1
]}

机构：

[1] Vertex Pharmaceut Inc, Cambridge, MA 02139 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 08期

关键词：

hepatitis C; protease inhibitors;

D O I：

10.1016/j.bmcl.2004.01.078

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We recently described the identification of an optimized alpha-ketoamide warhead for our series of HCV NS3(.)4A inhibitors. We report herein a series of HCV protease inhibitors incorporating 3-alkyl-substituted prolines in P-2. These compounds show exceptional enzymatic and cellular potency given their relatively small size. The marked enhancement of activity of these 3-substituted proline derivatives relative to previously reported 4-hydroxyproline derivatives constitutes additional evidence for the importance of the S-2 binding pocket as the defining pharmacophore for inhibition of the NS3(.)4A enzyme. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：1939 / 1942

页数：4

共 19 条

[1] Solution and solid-phase synthesis of potent inhibitors of Hepatitis C Virus NS3 proteinase
Beevers, R
Carr, MG
Jones, PS
Jordan, S
Kay, PB
Lazell, RC
Raynham, TM
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (04) : 641 - 643
[2] COREY EJ, 1967, TETRAHEDRON LETT, P2325
[3] DUNITZ JD, 1994, SCIENCE, V670, P264
[4] 1,4-ADDITION OF SECONDARY AND TERTIARY ALKYLZINC BROMIDES TO ALPHA,BETA-UNSATURATED KETONES WITHOUT A COPPER CATALYST
HANSON, MV
RIEKE, RD
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (43) : 10775 - 10776
[5] Hashimoto M, 1996, TETRAHEDRON, V52, P1931
[6] SYNTHESIS OF HOMOCHIRAL R-BACLOFEN FROM S-GLUTAMIC ACID
HERDEIS, C
HUBMANN, HP
[J]. TETRAHEDRON-ASYMMETRY, 1992, 3 (09) : 1213 - 1221
[7] TRANS-3-NORMAL-PROPYL-L-PROLINE IS A HIGHLY FAVORABLE, CONFORMATIONALLY RESTRICTED REPLACEMENT FOR METHIONINE IN THE C-TERMINAL TETRAPEPTIDE OF CHOLECYSTOKININ - STEREOSELECTIVE SYNTHESIS OF 3-ALLYL-L-PROLINE AND 3-NORMAL-PROPYL-L-PROLINE DERIVATIVES FROM 4-HYDROXY-L-PROLINE
HOLLADAY, MW
LIN, CW
MAY, CS
GARVEY, DS
WITTE, DG
MILLER, TR
WOLFRAM, CAW
NADZAN, AM
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (01) : 455 - 457
[8] Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products
Ingallinella, P
Altamura, S
Bianchi, E
Taliani, M
Ingenito, R
Cortese, R
De Francesco, R
Steinkühler, C
Pessi, A
[J]. BIOCHEMISTRY, 1998, 37 (25) : 8906 - 8914
[9] Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase/NTPase):: A comparative study of different C-terminals
Johansson, A
Poliakov, A
Åkerblom, E
Wiklund, K
Lindeberg, G
Winiwarter, S
Danielson, UH
Samuelsson, B
Hallberg, A
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (12) : 2551 - 2568
[10] Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
Lohmann, V
Körner, F
Koch, JO
Herian, U
Theilmann, L
Bartenschlager, R
[J]. SCIENCE, 1999, 285 (5424) : 110 - 113

← 1 2 →